Satya Prakash works at Biomedical Technology and Cell Therapy Research Laboratory in the department of Biomedical Engineering, Department of Experimental Medicine, Faculty of Medicine, McGill University, Canada. The primary research interest of this laboratory is in several innovative areas of artificial cells, microencapsulation, cell therapy, tissue engineering, nanomedicine, regenerative medicine, biomaterials, drug delivery, bacterial cell therapy, medical device engineering, and other biomedical technology developments. Specifically, the research team is investigating cholesterol lowering formulations, fatty liver therapeutics, therapeutic protein delivery, novel therapies for neurodegenerative diseases, inflammatory bowel diseases, wound healing, and formulations for use in colon and breast cancers. The research team is also investigating basic mechanisms for the design of artificial organ substitutes such as artificial kidney, liver and skin.
Bioengineering, Biomedicine, Cancer, Cell therapy, Gatreointestinal model, Heart health, Medical devices, Metabolic syndrome, Microencapsulation, Microbiome, Microbiota, NAFLD